Figure 1From: The effects of serum lipids on the in vitro activity of lumefantrine and atovaquone against Plasmodium falciparumIn-vitro drug susceptibility of Thai laboratory strain (TM267) to lumefantrine and atovaquone under culture conditions with varying concentrations of triglycerides (TG) in the supplemented serum (10% v/v). Figure a: IC50 for lumefantrine (ng/mL); figure b: IC50 for atovaquone (ng/mL).Back to article page